Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity

Metabolism: Clinical and Experimental

Volumn 65, Issue 12, 2016, Pages 1743-1754

  Chung, Heekyung ^a   Chou, Winjet ^a   Sears, Dorothy D ^a,b,c   Patterson, Ruth E ^b,c   Webster, Nicholas J G ^a,b,d   Ellies, Lesley G ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Hepatosteatosis; Insulin resistance; Obesity; Postmenopausal; Time restricted feeding

Indexed keywords

ACAA1A PROTEIN; ACADL PROTEIN; ACADVL PROTEIN; ACOX1 PROTEIN; CD36 ANTIGEN; CROT PROTEIN; FIBROBLAST GROWTH FACTOR 21; FITM2 PROTEIN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; LPIN1 PROTEIN; OXALOACETIC ACID; PEX11A PROTEIN; PLIN1 PROTEIN; PLIN2 PROTEIN; PROTEIN; PYRUVATE CARBOXYLASE; PYRUVATE DEHYDROGENASE KINASE 4; PYRUVATE KINASE; RNA; SLC27A1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INSULIN RESISTANCE; KETOGENESIS; LIPID DIET; LUNG GAS EXCHANGE; MENOPAUSAL SYNDROME; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TIME RESTRICTED FEEDING; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; C57BL MOUSE; CALORIC INTAKE; DIET THERAPY; DISEASE MODEL; FEEDING BEHAVIOR; GENE EXPRESSION PROFILING; GENETICS; PHYSIOLOGY; POSTMENOPAUSE;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FATTY LIVER; FEEDING BEHAVIOR; FEMALE; GENE EXPRESSION PROFILING; GLUCONEOGENESIS; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; OBESITY; POSTMENOPAUSE;

EID: 84991310045     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.09.006     Document Type: Article

References (48)

1. [1] Arthur, F.K., Adu-Frimpong, M., Osei-Yeboah, J., Mensah, F.O., Owusu, L., The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women. BMC Res Notes 6 (2013), 446–458.
2. [2] Heianza, Y., Arase, Y., Kodama, S., Hsieh, S.D., Tsuji, H., Saito, K., et al. Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care 36 (2013), 4007–4014.
3. [3] Morling, J.R., Balkau, B., Wild, S.H., Diabetes in women: a life-course approach. Menopause Int 19 (2013), 87–95.
4. [4] Wang, Z., Xu, M., Hu, Z., Shrestha, U.K., Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause 22 (2015), 667–673.
5. [5] Rodrigues, M.H., Bruno, A.S., Nahas-Neto, J., Santos, M.E., Nahas, E.A., Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. Gynecol Endocrinol 30 (2014), 325–329.
6. [6] Munsell, M.F., Sprague, B.L., Berry, D.A., Chisholm, G., Trentham-Dietz, A., Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev 36 (2014), 114–136.
7. [7] Barrett-Connor, E., The Rancho Bernardo study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection. Glob Heart 8 (2013), 1–27.
8. [8] Dorak, M.T., Karpuzoglu, E., Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet, 3, 2012, 268.
9. [9] Vitale, C., Miceli, M., Rosano, G.M., Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 10:Suppl. 2 (2007), 16–20.
10. [10] Kalyani, R.R., Lazo, M., Ouyang, P., Turkbey, E., Chevalier, K., Brancati, F., et al. Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care 37 (2014), 830–838.
11. [11] Meynet, O., Ricci, J.E., Caloric restriction and cancer: molecular mechanisms and clinical implications. Trends Mol Med 20 (2014), 419–427.
12. [12] Barnosky, A.R., Hoddy, K.K., Unterman, T.G., Varady, K.A., Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. Transl Res 164 (2014), 302–311.
13. [13] Patterson, R.E., Laughlin, G.A., LaCroix, A.Z., Hartman, S.J., Natarajan, L., Senger, C.M., et al. Intermittent fasting and human metabolic health. J Acad Nutr Diet 115 (2015), 1203–1212.
14. [14] Varady, K.A., Bhutani, S., Church, E.C., Klempel, M.C., Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 90 (2009), 1138–1143.
15. [15] Yokoyama, N.N., Denmon, A., Uchio, E.M., Jordan, M., Mercola, D., Zi, X., When anti-aging studies meet cancer chemoprevention: can anti-aging agent kill two birds with one blow?. Curr Pharmacol Rep 1 (2015), 420–433.
16. [16] Varady, K.A., Hellerstein, M.K., Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr 86 (2007), 7–13.
17. [17] Seimon, R.V., Roekenes, J.A., Zibellini, J., Zhu, B., Gibson, A.A., Hills, A.P., et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Mol Cell Endocrinol 418 Pt 2 (2015), 153–172.
18. [18] Varady, K.A., Allister, C.A., Roohk, D.J., Hellerstein, M.K., Improvements in body fat distribution and circulating adiponectin by alternate-day fasting versus calorie restriction. J Nutr Biochem 21 (2010), 188–195.
19. [19] Baumeier, C., Kaiser, D., Heeren, J., Scheja, L., John, C., Weise, C., et al. Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice. Biochim Biophys Acta 2015 (1851), 566–576.
20. [20] McCaffree, J., What you should know about calorie restriction. J Am Diet Assoc 104 (2004), 1524–1526.
21. [21] Sofer, S., Stark, A.H., Madar, Z., Nutrition targeting by food timing: time-related dietary approaches to combat obesity and metabolic syndrome. Adv Nutr 6 (2015), 214–223.
22. [22] Wegman, M.P., Guo, M.H., Bennion, D.M., Shankar, M.N., Chrzanowski, S.M., Goldberg, L.A., et al. Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolism. Rejuvenation Res 18 (2015), 162–172.
23. [23] Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E.A., Gill, S., et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 15 (2012), 848–860.
24. [24] Eckel-Mahan, K.L., Patel, V.R., de Mateo, S., Orozco-Solis, R., Ceglia, N.J., Sahar, S., et al. Reprogramming of the circadian clock by nutritional challenge. Cell 155 (2013), 1464–1478.
25. [25] Narasimamurthy, R., Hatori, M., Nayak, S.K., Liu, F., Panda, S., Verma, I.M., Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 109 (2012), 12662–12667.
26. [26] Carvas, J.M., Vukolic, A., Yepuri, G., Xiong, Y., Popp, K., Schmutz, I., et al. Period 2 gene mutant mice show compromised insulin-mediated endothelial nitric oxide release and altered glucose homeostasis. Front Physiol, 3, 2012, 337.
27. [27] Sherman, H., Genzer, Y., Cohen, R., Chapnik, N., Madar, Z., Froy, O., Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J 26 (2012), 3493–3502.
28. [28] Gill, S., Le, H.D., Melkani, G.C., Panda, S., Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science 347 (2015), 1265–1269.
29. [29] Balcombe, J.P., Barnard, N.D., Sandusky, C., Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43 (2004), 42–51.
30. [30] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
31. [31] Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH image to ImageJ: 25 years of image analysis. Nat Methods 9 (2012), 671–675.
32. [32] Sundaram, S., Yan, L., Time-restricted feeding reduces adiposity in mice fed a high-fat diet. Nutr Res 36 (2016), 603–611.
33. [33] Kamada, Y., Kiso, S., Yoshida, Y., Chatani, N., Kizu, T., Hamano, M., et al. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am J Physiol Gastrointest Liver Physiol 301 (2011), G1031–G1043.
34. [34] Brown, J.E., Mosley, M., Aldred, S., Intermittent fasting: a dietary intervention for prevention of diabetes and cardiovascular disease?. Br J Diabetes Vasc Dis 13 (2013), 68–72.
35. [35] Skaznik-Wikiel, M.E., Polotsky, A.J., The health pros and cons of continuous versus intermittent calorie restriction: more questions than answers. Maturitas 79 (2014), 275–278.
36. [36] Chaix, A., Zarrinpar, A., Miu, P., Panda, S., Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 20 (2014), 991–1005.
37. [37] Hevener, A., Reichart, D., Janez, A., Olefsky, J., Female rats do not exhibit free fatty acid-induced insulin resistance. Diabetes 51 (2002), 1907–1912.
38. [38] Riant, E., Waget, A., Cogo, H., Arnal, J.F., Burcelin, R., Gourdy, P., Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150 (2009), 2109–2117.
39. [39] Rogers, N.H., Perfield, J.W. II, Strissel, K.J., Obin, M.S., Greenberg, A.S., Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150 (2009), 2161–2168.
40. [40] Ribas, V., Nguyen, M.T., Henstridge, D.C., Nguyen, A.K., Beaven, S.W., Watt, M.J., et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 298 (2010), E304–E319.
41. [41] Duncan, M.J., Smith, J.T., Narbaiza, J., Mueez, F., Bustle, L.B., Qureshi, S., et al. Restricting feeding to the active phase in middle-aged mice attenuates adverse metabolic effects of a high-fat diet. Physiol Behav 167 (2016), 1–9.
42. [42] Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. JAMA 313 (2015), 2263–2273.
43. [43] Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6 (2000), 87–97.
44. [44] Eckel-Mahan, K., Sassone-Corsi, P., Metabolism and the circadian clock converge. Physiol Rev 93 (2013), 107–135.
45. [45] Marinac, C.R., Natarajan, L., Sears, D.D., Gallo, L.C., Hartman, S.J., Arredondo, E., et al. Prolonged nightly fasting and breast cancer risk: findings from NHANES (2009-2010). Cancer Epidemiol Biomarkers Prev 24 (2015), 783–789.
46. [46] Marinac, C.R., Nelson, S.H., Breen, C.I., Hartman, S.J., Natarajan, L., Pierce, J.P., et al. Prolonged nightly fasting and breast cancer prognosis. JAMA Oncol 2 (2016), 1049–1055.
47. [47] Moran-Ramos, S., Baez-Ruiz, A., Buijs, R.M., Escobar, C., When to eat? The influence of circadian rhythms on metabolic health: are animal studies providing the evidence?. Nutr Res Rev, 2016, 1–14.
48. [48] Longo, V.D., Panda, S., Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab 23 (2016), 1048–1059.